
    
      This will be a prospective, randomized, 3-arm parallel trial on 60 males with erectile
      dysfunction (ED) that have never been exposed to PDE5i therapy (naïve patients) will be
      enrolled. In each group, every patient will receive three treatment regimes (Viagra®50mg &
      Cialis®10mg, Viagra®100mg, Cialis®20mg), in different sequences of administration.
    
  